JNCI-Journal of the National Cancer Institute

Article	Citations
Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer	329
Correction to: RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study	221
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	189
Corrigendum to: Receptivity to a Nurse-Led Symptom Management Intervention among Highly Symptomatic Patients with Cance	178
Corrigendum to: Realizing the Promise of Personalized Colorectal Cancer Screening in Practice	132
BRCA1/2 germline sequencing in children and adolescents with cancer: it is the context that matters	126
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045	123
Pre- and post-diagnostic use of antihypertensive medications and stage I-III colorectal cancer survival: prospective cohort study	121
Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline	120
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity	117
Response to Liu and Zhang	109
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data	105
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United States	105
Lower survival for surgical treatment of human papillomavirus–related oropharynx cancer at community cancer centers	86
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021	66
Association of immunoglobulin E levels with glioma risk and survival	62
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort	61
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer	60
Retraction and Replacement of: Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening	59
Effect of chronic disease on racial difference in COVID-19–associated hospitalization among cancer patients	59
Surgical Care for Older Adults: The Importance of Patient-Centered Outcomes in Daily Practice	59
Publisher’s Note	58
Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	57
Advancing rapid cycle research in cancer care delivery: a National Cancer Institute workshop report	52
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)	51

The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer	49
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds	49
Correction to: RE: Grade Migration of Prostate Cancer in the United States During the Last Decade	45
Reviewers	45
Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations	45
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial	44
Response to Liu, Xiao, Liu, et al.	43
Colon, colorectal and all cancer incidence increase in the Young due to appendix reclassification	42
Response to Lehrer	42
RE: Use of artificial intelligence for cancer clinical trial enrollment	41
Editor’s Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex	41
Stat Bite: Estimated cumulative risk of female breast cancer incidence and mortality (ages 0-74) in 2022	40
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia	40
Housing Insecurity Among Patients With Cancer	40
Obligate and Potential Precursors of Melanoma	40
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130	40
Addressing Diversity, Equity, and Inclusion at the JNCI Journals	39
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study	39
Cancer Hazard Evaluations for Contemporary Needs: Highlights From New National Toxicology Program Evaluations and Methodological Advancements	39
Adverse birth outcomes of adolescent and young adult women diagnosed with cancer during pregnancy	38
Addressing Social Determinants of Health: Now Is the Time	37
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women	36
Combined individual participant data: highest-level evidence on obesity and colorectal cancer molecular subtypes	36
Correction to: Longitudinal e-Cigarette and Cigarette Use Among US Youth in the PATH Study (2013–2015)	36
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules	36
Response to Maltoni, Puccetti, Poli, et al.	36
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials	36
Clinical Benefit Scales and Trial Design: Some Statistical Issues	36
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials	35
Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial	35
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020	35
When the somatic genome informs the germline: the example of TP53	35
Modeling disparities in colorectal cancer outcomes: colonoscopy follow-up and quality are key	34
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)	34
RE: Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group	33
Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019	33
Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients	33
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities	33
Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis	32
Assessment of intermediate-term mortality following pancreatectomy for cancer	32
RET overexpression leads to increased brain metastatic competency in luminal breast cancer	32
Li-Fraumeni Syndrome in the Cancer Genomics Era	31
Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies	31
Cancer Surveillance Opportunities to Meet Prevention and Control Challenges	31
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model	31
Evaluating clinical utility of comprehensive genomic profiling—challenges and opportunities	30
Genotypic vs Phenotypic Risk Assessment for Melanoma	30
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer	30
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer	30
Understanding risk factors for endometrial cancer in young women	29

RE: Association of metformin use and cancer incidence: a systematic review and meta-analysis	29
The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor–Positive Breast Cancer	27
Physical activity, metabolites, and breast cancer associations	27
Response to Krieger	27
Response to Wu and Zhang	27
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer	26
Health insurance among survivors of childhood cancer following Affordable Care Act implementation	26
The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward	26
Reducing ovarian cancer mortality through screening: an impossible dream?	26
Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research	26
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405	26
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment	26
Response to Klar and Adams	26
Response to Khouri and Suissa	26
Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States	25
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab	25
Cancer Mortality in Latino Populations by Birthplace and Generation: A Complex Analysis	25
Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry	25
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	25
Comparing the efficacy and safety of first-line treatments for chronic lymphocytic leukemia: a network meta-analysis	24
Racial and socioeconomic disparities in non–small cell lung cancer molecular diagnostics uptake	24
Response to Huang, Rivero-Hinojosa, Ma, et al	24
Untangling the Relationship Between Clonal Hematopoiesis and Ovarian Cancer Therapies	24
Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and Ethnicity	23
Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer	23
Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017	23
Medication–Associated Phthalate Exposure and Childhood Cancer Incidence	23
Uptake of breast cancer screening practices in low- and middle-income countries: a systematic review and meta-analysis	23
Assessing the effect of the COVID-19 pandemic on 1-year cancer survival in the United States	23
World Trade Center Rescue and Recovery Workers: Cancer Increases Are Beginning to Emerge	22
The Development of Global Cancer Research at the United States National Cancer Institute	22
Banning Menthol Cigarettes: The Time Has Come	22
Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer	22
The association of where patients with prostate cancer live and receive care on racial treatment inequities	22
Benefit vs Harm of Internal Mammary Node Irradiation for Node-Positive Breast Cancer	21
Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma	21
COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns?	21
Gauging the efficacy of multicancer screening: the road ahead may be long and bumpy	21
The Unrelenting Impact of Poverty on Cancer: Structural Inequities Call for Research and Solutions on Structural Determinants	20
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial	20
Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma	20
Another Weak Link in the Electron Transport Chain: Variants in SUCLG2 and Risk for Pheochromocytoma and Paraganglioma	20
Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older	20
New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer	19
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology	19
Do Cell Phones Cause Brain Tumors? Another Piece of the Puzzle	19
Body mass index and molecular subtypes of colorectal cancer	19
Supporting evidence in phase 2 cancer trial protocols: a content analysis	19
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study	18
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355	18
Addressing health-related quality of life inequities in cancer: where do we go from here?	18
Mental health outcomes in a population-based cohort of patients with prostate cancer	18
Human papillomavirus–associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates—United States, 2001-2019	18
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001	18
Long-term aspirin use and cancer risk: a 20-year cohort study	18
Mass incarceration and cancer health disparities in the United States: reimagining models of care delivery	18
Vertical integration in oncology: what does it mean for patients with cancer?	18
Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer	18
Response to Sorscher	17
Re: Deng and Heybati	17
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer	17
Can time to deterioration in patient-reported outcomes be a surrogate for overall survival?	17
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time	17
Simulating the population impact of interventions to reduce racial gaps in breast cancer treatment	17
Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women	17
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants	17
The long economic shadow of a cancer diagnosis during adolescence or young adulthood	17
Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?	17
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival	16
Prevalence of anal cytology screening among persons with HIV and lack of access to high-resolution anoscopy at HIV care facilities	16
COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States	16
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma	16
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers	16
RE: The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis	16
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study	16
Geriatric assessment and management: is decreasing treatment toxicity good enough?	16
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer	16
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report	16
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	16
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17	16

The evolution of NCI’s Health Information National Trends Survey: methods, data, and future directions	15
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation	15
Cancer’s Lasting Financial Burden: Evidence From a Longitudinal Assessment	15
Augmenting randomized clinical trial data with historical control data: Precision medicine applications	15
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendees	15
Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States	15
Leadership Diversity and Development in the Nation’s Cancer Centers	15
Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis	15
Effects of exercise on inflammation in female survivors of nonmetastatic breast cancer: a systematic review and meta-analysis	15
Obstetrical and Perinatal Outcomes in Female Survivors of Childhood and Adolescent Cancer: A Population-Based Cohort Study	15
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients	15
A new perspective on mitigating lung cancer risks through smoking cessation and reduction	15
Assessment of Caregivers’ Burden When Caring for Patients With Pancreatic and Periampullary Cancer	15
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions	15
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions	15
The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis	15
Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older	14
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer	14
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics	14
Childhood body mass index trajectories, adult-onset type 2 diabetes, and obesity-related cancers	14
Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020	14
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402	14
Prevalence by therapy line and incidence of breast cancer brain metastases in 18,075 patients	14
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C	14
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research	14
Helicobacter pylori Modulated Host Immunity in Gastric Cancer Patients With S-1 Adjuvant Chemotherapy	14
Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer	14
RE: Timing of depression in relation to risk of ovarian cancer	13
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination	13
Corrigendum to: p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women	13
Workforce Caring for Cancer Survivors in the United States: Estimates and Projections of Use	13
Response to Oleribe	13
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019	13
Effects of a high-fiber, high-fruit and high-vegetable, low-fat dietary intervention on the rectal tissue microbiome	13
RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data	13
Determinants of late metastases in renal cell carcinoma	13
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study	13
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review	13
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis	13
Correction to: Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules	13
Editor’s Note on: Structural Basis for Depletion of Heat Shock Protein 90 Client Proteins by Deguelin	12
Corrigendum to: Master protocol trial design for efficient and rational evaluation of novel therapeutic oncology devices	12
A predictor of response in HER2+ breast cancer—at last!	12
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study	12
Contribution of health insurance to racial and ethnic disparities in advanced-stage diagnosis of 10 cancers	12
Reaffirming our values: the Journal of the National Cancer Institute’s commitment to excellence and society	12
Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study	12
Early identification of weight loss trajectories in advanced cancer and associations with survival	12
Correction to: Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome	12
Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors	12
NCCN guideline–concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers	12
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer	12
Expanding the list of cancers recognized to be caused by infectious agents	12
Lung cancer screening with low-dose computed tomography—where do we go from here?	12
Executing plans to enhance diversity across cancer centers in the United States: opportunities and challenges	12
Noninferiority trials in oncology: need for improvement, or a paradigm shift?	12
Response to Lehrer and Rheinstein	12
RE: Autoimmune disease and the risk of anal cancer in the US elderly population	12
You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective	12
Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study	12
Evaluating colonoscopy quality by performing provider type	12
Decreasing incidence of conjunctival squamous cell carcinoma in people with HIV in South Africa	11
Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy	11
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia	11
Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old	11
Reply to Bertucci, De Nonneville, and Finetti	11
Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer	11
Fertility-preserving treatments for endometrial intraepithelial neoplasia: the known unknowns	11
Medicaid expansion and racial disparity in timely multidisciplinary treatment in muscle invasive bladder cancer	11
Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over	11
RE: Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density	10
Response to Pederson et al. and Chlebowski et al.	10
Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeutics	10
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment	10
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors	10
The enormous and continuing challenge of maintaining hope in patients with advanced cancer	10
Cancer control co-benefits of the climate-related provisions in the American Inflation Reduction Act	10
Predicting prostate cancer grade reclassification on active surveillance using a deep learning–based grading algorithm	10
RE: Spatial intratumor heterogeneity of programmed cell death ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer	10
Randomized trial of dyadic-report vs proxy-report and self-report symptom assessment for pediatric patients receiving cancer treatments	10
Response to Omoleye, Esserman, Olufunmilayo	10
RE: Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study	10
Palliative prognostic scores for survival prediction of cancer patients: a systematic review and meta-analysis	10
Centering patients with advanced cancer includes supporting their caregivers	10
Vitamin D receptor gene polymorphisms, bioavailable 25-hydroxyvitamin D, and hepatocellular carcinoma survival	9
Histopathological response to chemotherapy and survival of mucinous type gastric cancer	9
Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk	9
A national evaluation of adjuvant chemotherapy in pT4N0M0 colon cancer from the National Cancer Database	9
Predictive Biomarkers: Progress on the Road to Personalized Cancer Immunotherapy	9
Cancer Mortality Patterns by Birthplace and Generation Status of Mexican Latinos: The Multiethnic Cohort	9
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients	9
Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density	9
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer	9
RE: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study	9
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line col	9